145 related articles for article (PubMed ID: 3155428)
21. Evaluation of the alpha and beta blocking effects of intravenous labetalol on left ventricular function in coronary artery disease.
Gagnon RM; Presant S; Morissette M
Can J Cardiol; 1985; 1(4):259-62. PubMed ID: 2996729
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol.
Kenny D; Pagel PS; Warltier DC
Basic Res Cardiol; 1992; 87(5):465-77. PubMed ID: 1334401
[TBL] [Abstract][Full Text] [Related]
23. Acute hemodynamic and electrophysiologic effects of propranolol in patients receiving diltiazem.
Wolfe CL; Tilton GD; Hillis LD; el Ashram N; Winniford MD
Am J Cardiol; 1985 Jul; 56(1):47-50. PubMed ID: 4014039
[TBL] [Abstract][Full Text] [Related]
24. Acute antiischaemic properties of high dosages of intravenous diltiazem in humans in relation to its coronary and systemic haemodynamic effects.
Remme WJ; van Hoogenhuyze DC; Hofman A; Storm CJ; Krauss XH; Kruyssen HA
Eur Heart J; 1987 Sep; 8(9):965-74. PubMed ID: 3665956
[TBL] [Abstract][Full Text] [Related]
25. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease.
Rousseau MF; Etienne J; Van Mechelen H; Veriter C; Pouleur H
J Cardiovasc Pharmacol; 1984; 6(5):833-9. PubMed ID: 6209488
[TBL] [Abstract][Full Text] [Related]
27. Systemic, left ventricular and coronary hemodynamic effects of intravenous diltiazem in coronary artery disease.
Joyal M; Cremer KF; Pieper JA; Feldman RL; Pepine CJ
Am J Cardiol; 1985 Sep; 56(7):413-7. PubMed ID: 4036821
[TBL] [Abstract][Full Text] [Related]
28. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
[TBL] [Abstract][Full Text] [Related]
29. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.
Kern MJ; Petru MA; Ferry DR; Eilen SD; Barr WK; Porter CB; O'Rourke RA
J Am Coll Cardiol; 1985 Jun; 5(6):1438-50. PubMed ID: 2860147
[TBL] [Abstract][Full Text] [Related]
30. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
Silke B; Nelson GI; Ahuja RC; Taylor SH
Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
van Woerkens LJ; van der Giessen WJ; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
[TBL] [Abstract][Full Text] [Related]
32. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
Prida XE; Feldman RL; Hill JA; Pepine CJ
Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
[TBL] [Abstract][Full Text] [Related]
33. [Intravenous labetalol in normotensive coronary patients. Effects on hemodynamics and myocardial metabolism].
Ourbak P; Lardoux H; Pornin M; Bouziri S; Allal J; Duong TC; Sellier P; Maurice M
Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1089-96. PubMed ID: 3929738
[TBL] [Abstract][Full Text] [Related]
34. Effects of nicardipine on left ventricular function and energetics in man.
Lambert CR; Hill JA; Feldman RL; Pepine CJ
Int J Cardiol; 1986 Mar; 10(3):237-50. PubMed ID: 3957469
[TBL] [Abstract][Full Text] [Related]
35. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
Materne P; Legrand V; Vandormael M; Collignon P; Kulbertus HE
Am J Cardiol; 1984 Oct; 54(7):733-7. PubMed ID: 6486022
[TBL] [Abstract][Full Text] [Related]
37. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
38. Haemodynamic analysis of the effects of nicardipine and metoprolol alone and in combination in coronary artery disease.
Silke B; Verma SP; Frais MA; Reynolds G; Jackson N; Taylor SH
Eur Heart J; 1985 Nov; 6(11):930-8. PubMed ID: 4076202
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans.
Bourassa MG; Cote P; Theroux P; Tubau JF; Genain C; Waters DD
Chest; 1980 Jul; 78(1 Suppl):224-30. PubMed ID: 7398410
[TBL] [Abstract][Full Text] [Related]
40. [Responses of plasma eicosanoids and hemodynamics to myocardial ischemia and the salutary effect of calcium entry blocker].
Takase B
Nihon Ika Daigaku Zasshi; 1990 Feb; 57(1):42-54. PubMed ID: 2329180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
